MedPath

Naftifine

Generic Name
Naftifine
Brand Names
Naftin
Drug Type
Small Molecule
Chemical Formula
C21H21N
CAS Number
65472-88-0
Unique Ingredient Identifier
4FB1TON47A

Overview

Naftifine is a synthetic, broad spectrum, antifungal agent and allylamine derivative for the topical treatment of tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans and Epidermophyton floccosum.

Background

Naftifine is a synthetic, broad spectrum, antifungal agent and allylamine derivative for the topical treatment of tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans and Epidermophyton floccosum.

Indication

For the topical treatment of tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans and Epidermophyton floccosum.

Associated Conditions

  • Tinea Corporis
  • Tinea Cruris
  • Tinea Pedis

FDA Approved Products

Naftifine Hydrochloride
Manufacturer:Taro Pharmaceuticals U.S.A., Inc.
Route:TOPICAL
Strength:20 mg in 1 g
Approved: 2018/05/25
NDC:51672-1368
Naftifine hydrochloride
Manufacturer:Xiromed, LLC
Route:TOPICAL
Strength:20 mg in 1 g
Approved: 2021/01/15
NDC:70700-161
Naftin
Manufacturer:Sebela Pharmaceuticals Inc.
Route:TOPICAL
Strength:2 g in 100 g
Approved: 2023/12/12
NDC:54766-772
Naftin
Manufacturer:Merz Pharmaceuticals, LLC
Route:TOPICAL
Strength:10 mg in 1 g
Approved: 2013/04/25
NDC:0259-4126
Naftifine Hydrochloride
Manufacturer:Taro Pharmaceuticals U.S.A., Inc.
Route:TOPICAL
Strength:10 mg in 1 g
Approved: 2018/05/25
NDC:51672-1362

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath